Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Teroxirone inhibited growth of human non-small cell lung cancer cells by activating p53

Journal Article · · Toxicology and Applied Pharmacology
; ; ; ;  [1];  [2];  [3];  [4];  [1]
  1. Department of Life Science, National Taiwan Normal University, Taipei, Taiwan (China)
  2. Department of Biotechnology, Kaohsiung Medical University, Kaohsiung, Taiwan (China)
  3. Department of Human Development and Family Studies, National Taiwan Normal University, Taipei, Taiwan (China)
  4. Department of Chemistry, National Taiwan Normal University, Taipei, Taiwan (China)

In this work, we demonstrated that the growth of human non-small-cell-lung-cancer cells H460 and A549 cells can be inhibited by low concentrations of an epoxide derivative, teroxirone, in both in vitro and in vivo models. The cytotoxicity was mediated by apoptotic cell death through DNA damage. The onset of ultimate apoptosis is dependent on the status of p53. Teroxirone caused transient elevation of p53 that activates downstream p21 and procaspase-3 cleavage. The presence of caspase-3 inhibitor reverted apoptotic phenotype. Furthermore, we showed the cytotoxicity of teroxirone in H1299 cells with stable ectopic expression of p53, but not those of mutant p53. A siRNA-mediated knockdown of p53 expression attenuated drug sensitivity. The in vivo experiments demonstrated that teroxirone suppressed growth of xenograft tumors in nude mice. Being a potential therapeutic agent by restraining cell growth through apoptotic death at low concentrations, teroxirone provides a feasible perspective in reversing tumorigenic phenotype of human lung cancer cells. - Highlights: • Teroxirone repressed tumor cell growth in nude mice of human lung cancer cells. • The apoptotic cell death reverted by caspase-3 inhibitor is related to p53 status. • Teroxirone provides a good candidate for lung cancer treatment.

OSTI ID:
22285493
Journal Information:
Toxicology and Applied Pharmacology, Journal Name: Toxicology and Applied Pharmacology Journal Issue: 1 Vol. 273; ISSN TXAPA9; ISSN 0041-008X
Country of Publication:
United States
Language:
English

Similar Records

p53 status is a major determinant of effects of decreasing peroxiredoxin I expression on tumor growth and response of lung cancer cells to treatment
Journal Article · Thu Nov 30 23:00:00 EST 2006 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:20850272

Enhanced radiosensitization of p53 mutant cells by oleamide
Journal Article · Fri Mar 31 23:00:00 EST 2006 · International Journal of Radiation Oncology, Biology and Physics · OSTI ID:20793433

The enhancing effect of genistein on apoptosis induced by trichostatin A in lung cancer cells with wild type p53 genes is associated with upregulation of histone acetyltransferase
Journal Article · Sun Jan 31 23:00:00 EST 2016 · Toxicology and Applied Pharmacology · OSTI ID:22687893